제목 | Impact of Diffusing Lung Capacity Before and After Neoadjuvant Concurrent Chemoradiation on Postoperative Pulmonary Complications Among Patients With Stage IIIA/N2 Non-Small-Cell Lung Cancer | ||
---|---|---|---|
작성자 | 관리자 | 등록일 | 2020-05-14 |
내용
Impact of Diffusing Lung Capacity Before and After Neoadjuvant Concurrent Chemoradiation on Postoperative Pulmonary Complications Among Patients With Stage IIIA/N2 Non-Small-Cell Lung Cancer
- PMID: 31924201
- PMCID: PMC6954564
- DOI: 10.1186/s12931-019-1254-0
Abstract
Background and objective: This study aims to evaluate the impact of diffusing capacity of the lung for carbon monoxide (DLco) before and after neoadjuvant concurrent chemoradiotherapy (CCRT) on postoperative pulmonary complication (PPC) among stage IIIA/N2 non-small-cell lung cancer (NSCLC) patients.
Methods: We retrospectively studied 324 patients with stage IIIA/N2 NSCLC between 2009 and 2016. Patients were classified into 4 groups according to DLco before and after neoadjuvant CCRT; normal-to-normal (NN), normal-to-low (NL), low-to-low (LL), and low-to-very low (LVL). Low DLco and very low DLco were defined as DLco < 80% predicted and DLco < 60% predicted, respectively.
Results: On average, DLco was decreased by 12.3% (±10.5) after CCRT. In multivariable-adjusted analyses, the incidence rate ratio (IRR) for any PPC comparing patients with low DLco to those with normal DLco before CCRT was 2.14 (95% confidence interval (CI) = 1.36-3.36). Moreover, the IRR for any PPC was 3.78 (95% CI = 1.68-8.49) in LVL group compared to NN group. The significant change of DLco after neoadjuvant CCRT had an additional impact on PPC, particularly after bilobectomy or pneumonectomy with low baseline DLco.
Conclusions: The DLco before CCRT was significantly associated with risk of PPC, and repeated test of DLco after CCRT would be helpful for risk assessment, particularly in patients with low DLco before neoadjuvant CCRT.
Keywords: Dlco; Non-small cell lung Cancer; Outcomes; Postoperative complication.
Conflict of interest statement
The authors declare that they have no competing interests.